{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:40:21Z","timestamp":1793868021083,"version":"4.6.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1053\/j.seminhematol.2023.11.002","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T12:26:12Z","timestamp":1700742372000},"page":"277-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["DLBCL arising from indolent lymphomas: How are they different?"],"prefix":"10.1053","volume":"60","author":[{"given":"Erin M.","family":"Parry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Roulland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6021-5044","authenticated-orcid":false,"given":"Jessica","family":"Okosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.002_bib0001","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","article-title":"Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone","volume":"111","author":"Feldman","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.002_bib0002","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.2011.102","article-title":"Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a study of seven cases","volume":"24","author":"Shao","year":"2011","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.002_bib0003","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/PAS.0b013e31826cb1d1","article-title":"Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases","volume":"37","author":"Martinez","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.002_bib0004","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.humpath.2014.10.021","article-title":"Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients","volume":"46","author":"Geyer","year":"2015","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.002_bib0005","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/leu.2015.21","article-title":"Diagnostic and prognostic role of PET\/CT in patients with chronic lymphocytic leukemia and progressive disease","volume":"29","author":"Mauro","year":"2015","journal-title":"Leukemia"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.002_bib0006","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00277-018-3390-x","article-title":"Diagnosis of Richter transformation in chronic lymphocytic leukemia: histology tips the scales","volume":"97","author":"Federmann","year":"2018","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.002_bib0007","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1182\/blood.2020008243","article-title":"Is it time for PET-guided therapy in follicular lymphoma?","volume":"139","author":"Trotman","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.002_bib0008","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/his.13024","article-title":"Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review","volume":"69","author":"Soilleux","year":"2016","journal-title":"Histopathology"},{"issue":"17","key":"10.1053\/j.seminhematol.2023.11.002_bib0009","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1053\/j.seminhematol.2023.11.002_bib0010","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma","volume":"26","author":"Al-Tourah","year":"2008","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1053\/j.seminhematol.2023.11.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource","author":"Link","year":"2013","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.002_bib0012","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","article-title":"Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)","volume":"126","author":"Wagner-Johnston","year":"2015","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminhematol.2023.11.002_bib0013","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1200\/JCO.2015.65.7163","article-title":"Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to first-line immunochemotherapy in the PRIMA trial","volume":"34","author":"Sarkozy","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.002_bib0014","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/bjh.14831","article-title":"Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group","volume":"178","author":"Alonso-\u00c1lvarez","year":"2017","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.002_bib0015","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/S2352-3026(18)30090-5","article-title":"Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis","volume":"5","author":"Federico","year":"2018","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0016","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clml.2022.09.003","article-title":"Risk factors for and outcomes of follicular lymphoma histological transformation at first progression in the GALLIUM study","volume":"23","author":"Casulo","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.002_bib0017","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood.2019000258","article-title":"Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma","volume":"134","author":"Freeman","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.002_bib0018","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1182\/blood-2013-11-516229","article-title":"How we treat Richter syndrome","volume":"123","author":"Parikh","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.002_bib0019","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjh.12458","article-title":"Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients","volume":"162","author":"Parikh","year":"2013","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41375-020-0797-x","article-title":"Richter transformation in chronic lymphocytic leukemia (CLL)\u2014a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials","volume":"35","author":"Al-Sawaf","year":"2021","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2023.11.002_bib0021","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.70.2282","article-title":"BTKC481S-mediated resistance to ibrutinib in chronic lymphocytic leukemia","author":"Woyach","year":"2017","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1053\/j.seminhematol.2023.11.002_bib0022","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1200\/JCO.21.01210","article-title":"Acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia: results of the first randomized phase III trial","volume":"39","author":"Byrd","year":"2021","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.002_bib0023","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood.2021015014","article-title":"Enduring undetectable MRD and updated outcomes in relapsed\/refractory CLL after fixed-duration venetoclax-rituximab","volume":"140","author":"Seymour","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.002_bib0024","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMra2102568","article-title":"Marginal-zone lymphomas","volume":"386","author":"Rossi","year":"2022","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.002_bib0025","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","article-title":"Histologic transformation in marginal zone lymphomas","volume":"26","author":"Conconi","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2023.11.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00138","article-title":"Risk factors for transformation to higher-grade lymphoma and its impact on survival in a large cohort of patients with marginal zone lymphoma from a single institution","author":"Alderuccio","year":"2018","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-023-00831-9","article-title":"Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study","volume":"13","author":"Kalashnikov","year":"2023","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.002_bib0028","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ajh.24477","article-title":"Histological transformation to diffuse large B-cell lymphoma in patients with Waldenstr\u00f6m macroglobulinemia","volume":"91","author":"Castillo","year":"2016","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.002_bib0029","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1182\/bloodadvances.2022007331","article-title":"High frequency of central nervous system involvement in transformed Waldenstr\u00f6m macroglobulinemia","volume":"6","author":"Durot","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/leu.2016.175","article-title":"Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma","volume":"31","author":"Bouska","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.002_bib0031","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1182\/blood-2017-03-691345","article-title":"Can histologic transformation of follicular lymphoma be predicted and prevented?","volume":"130","author":"Kridel","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: a clonal evolution study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0033","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.002_bib0034","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.002_bib0035","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.002_bib0036","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/blood.2022018719","article-title":"Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns","volume":"142","author":"Dreval","year":"2023","journal-title":"Blood"},{"issue":"15","key":"10.1053\/j.seminhematol.2023.11.002_bib0037","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2008-08-174839","article-title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone","volume":"113","author":"Carlotti","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.002_bib0038","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood-2010-03-272278","article-title":"Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones","volume":"116","author":"Eide","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.002_bib0039","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1084\/jem.20131448","article-title":"Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome","volume":"210","author":"Fabbri","year":"2013","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2023.11.002_bib0040","series-title":"Advances in immunology [Internet]","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.ai.2021.05.002","article-title":"Chapter Two - Follicular lymphoma dynamics","author":"Milpied","year":"2021"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.002_bib0041","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.002_bib0042","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1182\/blood.2019002279","article-title":"IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution","volume":"135","author":"Odabashian","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0043","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1158\/2159-8290.CD-11-0208","article-title":"Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation","volume":"2","author":"Weigert","year":"2012","journal-title":"Cancer Discov"},{"issue":"13","key":"10.1053\/j.seminhematol.2023.11.002_bib0044","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1200\/JCO.2013.52.8190","article-title":"Translocation: a predictive blood biomarker for follicular lymphoma","volume":"32","author":"Roulland","year":"2014","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.002_bib0045","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2159-8290.CD-23-0111","article-title":"Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors","volume":"13","author":"Schroers-Martin","year":"2023","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.002_bib0046","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/2159-8290.CD-19-0116","article-title":"Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma","volume":"10","author":"Mondello","year":"2020","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.002_bib0047","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.2020008743","article-title":"KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas","volume":"138","author":"Heward","year":"2021","journal-title":"Blood"},{"issue":"21","key":"10.1053\/j.seminhematol.2023.11.002_bib0048","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1182\/bloodadvances.2021005284","article-title":"Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network","volume":"6","author":"Crouch","year":"2022","journal-title":"Blood Adv"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.002_bib0049","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41375-018-0043-y","article-title":"Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma","volume":"32","author":"Araf","year":"2018","journal-title":"Leukemia"},{"issue":"21","key":"10.1053\/j.seminhematol.2023.11.002_bib0050","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1182\/blood.2020009855","article-title":"Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma","volume":"137","author":"Haebe","year":"2021","journal-title":"Blood"},{"issue":"364","key":"10.1053\/j.seminhematol.2023.11.002_bib0051","doi-asserted-by":"crossref","first-page":"364ra155","DOI":"10.1126\/scitranslmed.aai8545","article-title":"Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA","volume":"8","author":"Scherer","year":"2016","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.002_bib0052","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s41587-021-00981-w","article-title":"Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA","volume":"39","author":"Kurtz","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.002_bib0053","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41590-018-0181-4","article-title":"Human germinal center transcriptional programs are de-synchronized in B cell lymphoma","volume":"19","author":"Milpied","year":"2018","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.002_bib0054","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood-2018-08-862292","article-title":"Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints","volume":"133","author":"Andor","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.002_bib0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1158\/2643-3230.BCD-21-0075","article-title":"Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II Expression","volume":"3","author":"Han","year":"2022","journal-title":"Blood Cancer Discov"},{"key":"10.1053\/j.seminhematol.2023.11.002_bib0056","doi-asserted-by":"crossref","unstructured":"Attaf N, Dong C, Gil L, et al. Functional plasticity and recurrent cell states of malignant B cells in follicular lymphoma [Internet]. Biorxiv; 2022 [accessed 17.05.22]. Available from: https:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2022.04.06.487285.","DOI":"10.1101\/2022.04.06.487285"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-52768-7","article-title":"Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2023.11.002_bib0058","unstructured":"Sarkozy C, Wu S, Takata K, et al. Integrated single cell analysis reveals co-evolution of malignant B cells and the tumor microenvironment in transformed follicular lymphoma [Internet]. bioRxiv; 2022 [accessed 25.07.23]. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2022.11.17.516951v1."},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0059","first-page":"11","article-title":"Richter syndrome: Novel insights into the biology of transformation","volume":"142","author":"Parry","year":"2023","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.002_bib0060","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2023.11.002_bib0061","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-08-3266","article-title":"Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome","volume":"15","author":"Rossi","year":"2009","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.002_bib0062","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3324\/haematol.2021.278304","article-title":"The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation","volume":"107","author":"Visentin","year":"2022","journal-title":"Haematologica"},{"issue":"15","key":"10.1053\/j.seminhematol.2023.11.002_bib0063","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","article-title":"Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome","volume":"122","author":"Chigrinova","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.002_bib0064","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e31804bdaf8","article-title":"IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution","volume":"31","author":"Mao","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0065","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41591-022-02113-6","article-title":"Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome","volume":"29","author":"Parry","year":"2023","journal-title":"Nat Med"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.002_bib0066","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med"},{"issue":"20","key":"10.1053\/j.seminhematol.2023.11.002_bib0067","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/blood.2020005650","article-title":"Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia","volume":"137","author":"Klintman","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.002_bib0068","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1016\/S2352-3026(21)00305-7","article-title":"Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1-2 study","volume":"8","author":"Eyre","year":"2021","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0069","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41467-022-34642-6","article-title":"Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis","volume":"14","author":"Bros\u00e9us","year":"2023","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2023.11.002_bib0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41467-017-00210-6","article-title":"Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia","volume":"8","author":"Knittel","year":"2017","journal-title":"Nat Commun"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2023.11.002_bib0071","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2022-163211","article-title":"Generation of richter transformation models throughout chronic lymphocytic leukemia patient-derived xenografts: a clonal evolution model","volume":"140","author":"Playa-Albinyana","year":"2022","journal-title":"Blood"},{"issue":"25","key":"10.1053\/j.seminhematol.2023.11.002_bib0072","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood.2021011993","article-title":"Understanding CLL biology through mouse models of human genetics","volume":"138","author":"ten Hacken","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.11.002_bib0073","first-page":"OF1","article-title":"In vivo modeling of CLL transformation to richter syndrome reveals convergent evolutionary paths and therapeutic vulnerabilities","author":"ten Hacken","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.002_bib0074","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood.2020008276","article-title":"B-cell receptor signaling and genetic lesions in TP53 and CDKN2A\/CDKN2B cooperate in Richter transformation","volume":"138","author":"Chakraborty","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.11.002_bib0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41467-022-35778-1","article-title":"Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation","volume":"14","author":"Hing","year":"2023","journal-title":"Nat Commun"},{"issue":"20","key":"10.1053\/j.seminhematol.2023.11.002_bib0076","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1158\/1078-0432.CCR-19-0273","article-title":"E\u00b5-TCL1xMyc: a novel mouse model for concurrent CLL and B-cell lymphoma","volume":"25","author":"Lucas","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10.1053\/j.seminhematol.2023.11.002_bib0077","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121438","article-title":"Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies","volume":"3","author":"Hacken","year":"2018","journal-title":"JCI Insight"},{"issue":"13","key":"10.1053\/j.seminhematol.2023.11.002_bib0078","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1158\/0008-5472.CAN-17-4004","article-title":"Novel richter syndrome xenograft models to study genetic architecture, biology, and therapy responses","volume":"78","author":"Vaisitti","year":"2018","journal-title":"Cancer Res"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.002_bib0079","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41375-021-01181-w","article-title":"BET proteolysis targeted chimera-based therapy of novel models of Richter transformation-diffuse large B-cell lymphoma","volume":"35","author":"Fiskus","year":"2021","journal-title":"Leukemia"},{"issue":"14","key":"10.1053\/j.seminhematol.2023.11.002_bib0080","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/bloodadvances.2022009415","article-title":"Unraveling the genetics of transformed splenic marginal zone lymphoma","volume":"7","author":"Grau","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.002_bib0081","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ajh.25694","article-title":"Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma","volume":"95","author":"Qian","year":"2020","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.002_bib0082","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1038\/bcj.2017.72","article-title":"From Waldenstr\u00f6m's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation","volume":"7","author":"Jim\u00e9nez","year":"2017","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.002_bib0083","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ajh.25697","article-title":"Impact of MYD88L265P mutation status on histological transformation of Waldenstr\u00f6m Macroglobulinemia","volume":"95","author":"Zanwar","year":"2020","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.002_bib0084","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1200\/JCO.19.02314","article-title":"Genomic landscape of Waldenstr\u00f6m macroglobulinemia and its impact on treatment strategies","volume":"38","author":"Treon","year":"2020","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1053\/j.seminhematol.2023.11.002_bib0085","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/bloodadvances.2018022962","article-title":"Insights into the genomic landscape of MYD88 wild-type Waldenstr\u00f6m macroglobulinemia","volume":"2","author":"Hunter","year":"2018","journal-title":"Blood Adv"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.002_bib0086","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2023.11.002_bib0087","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1053\/j.seminhematol.2023.11.002_bib0088","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.002_bib0089","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41375-023-01868-2","article-title":"Exploring the genetic landscape of HCV-related B-cell lymphomas using whole exome sequencing","volume":"37","author":"Armand","year":"2023","journal-title":"Leukemia"},{"issue":"18","key":"10.1053\/j.seminhematol.2023.11.002_bib0090","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","article-title":"Cell of origin of transformed follicular lymphoma","volume":"126","author":"Kridel","year":"2015","journal-title":"Blood."},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.002_bib0091","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.002_bib0092","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-cancerbio-030518-055734","article-title":"Taming the heterogeneity of aggressive lymphomas for precision therapy","volume":"3","author":"Young","year":"2019","journal-title":"Annu Rev Cancer Biol"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.002_bib0093","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-Cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.002_bib0094","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.17811","article-title":"Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?","volume":"196","author":"Morin","year":"2022","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.002_bib0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JCO.18.00400","article-title":"Cause of death in follicular lymphoma in the first decade of the rituximab era: a pooled analysis of French and US cohorts","volume":"37","author":"Sarkozy","year":"2019","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"15","key":"10.1053\/j.seminhematol.2023.11.002_bib0096","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1200\/JCO.2005.05.0187","article-title":"Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation","volume":"24","author":"Tsimberidou","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:28:22Z","timestamp":1758522502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196323000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":96,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0037196323000896"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.11.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DLBCL arising from indolent lymphomas: How are they different?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}